Eton Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ETON Eton Pharmaceuticals Inc
LIFW MSP Recovery Inc
ASNS Actelis Networks Inc
AHI Advanced Health Intelligence Ltd
OTLK Outlook Therapeutics Inc
PBHC Pathfinder Bancorp Inc (MARYLAND)
CMA Comerica Inc
IART Integra Lifesciences Holdings Corp
ARKW.SO ARK Next Generation Internet ETF
AGNC Agnc Investment Corp
Go

Health Care : Pharmaceuticals | Small Cap Growth

Eton Pharmaceuticals, Inc. is a pharmaceutical company, which is developing, acquiring and commercializing products to address unmet needs in patients suffering from rare diseases. It has three commercial rare disease products, ALKINDI SPRINKLE for the treatment of adrenocortical insufficiency, Carglumic Acid for the treatment of hyperammonemia due to N-acetylglutamate synthase deficiency, and Betaine Anhydrous for the treatment of homocystinuria. It also has three additional product candidates in late-stage development. The Company is developing dehydrated alcohol injection, which has received Orphan Drug Designation for the treatment of methanol poisoning, ZENEO hydrocortisone autoinjector for the treatment of adrenal crisis, and ET-400. Its dehydrated alcohol injection product candidate is under review for the treatment of methanol poisoning. Its ZENEO hydrocortisone autoinjector product candidate is a needle-free autoinjector under development for the treatment of adrenal crisis.

Postmarket

Last Trade: Delayed
$4.14

Change Since Close Change Since Close Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.: 0.10 (2.48%)

Bid: --

Ask: --

B/A Size: --

Market Hours

Closing Price: $4.04

Day's Change: 0.13 (3.32%)

Bid close: --

Ask close: --

B/A Size: --

Day's High: 4.10

Day's Low: 3.90

Volume (Light) Volume: 93,192 10-day average volume: 185,397: 93,192

Today's News, October 04, 2023
6:50 am ET	Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone(Globe Newswire)
August 23, 2023
6:50 am ET	Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference(Globe Newswire)
August 14, 2023
9:31 am ET	Thinking about buying stock in Tupperware Brands, Eton Pharmaceuticals, StealthGas, Archer Aviation, or Amyris? InvestorsObserver issues critical PriceWatch Alerts for TUP, ETON, GASS, ACHR, and AMRS. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)
August 11, 2023
9:31 am ET	Thinking about buying stock in Cellebrite DI, Milestone Pharmaceuticals, Palatin Technologies, Limbach Holdings, or Eton Pharmaceuticals? InvestorsObserver issues critical PriceWatch Alerts for CLBT, MIST, PTN, LMB, and ETON. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)
August 10, 2023
4:01 pm ET	Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results(Globe Newswire)
August 01, 2023
4:05 pm ET	Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023(Globe Newswire)
July 30, 2023
10:00 am ET	Calling All Eton Pharmaceuticals, Inc. (ETON) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today! NEW YORK, NY / ACCESSWIRE / July 30, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ:ETON). Investors who purchased Eton...(Accesswire)
July 29, 2023
3:36 pm ET	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON NEW YORK, NY / ACCESSWIRE / July 29, 2023 / Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc.("Eton" or the "Company") (NASDAQ: ETON). Such investors are advised to contact Robert S. Willoughby at...(Accesswire)
July 28, 2023
11:01 am ET	Calling All Eton Pharmaceuticals, Inc. (ETON) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today! NEW YORK, NY / ACCESSWIRE / July 28, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ:ETON). Investors who purchased Eton...(Accesswire)
July 27, 2023
11:02 am ET	Calling All Eton Pharmaceuticals, Inc. (ETON) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today! NEW YORK, NY / ACCESSWIRE / July 27, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ:ETON). Investors who purchased Eton...(Accesswire)
July 26, 2023
10:14 am ET	Calling All Eton Pharmaceuticals, Inc. (ETON) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today! NEW YORK, NY / ACCESSWIRE / July 26, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ:ETON). Investors who purchased Eton...(Accesswire)
July 25, 2023
3:16 pm ET	Calling All Eton Pharmaceuticals, Inc. (ETON) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today! NEW YORK, NY / ACCESSWIRE / July 25, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ:ETON). Investors who purchased Eton...(Accesswire)
July 23, 2023
1:46 pm ET	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON New York, New York--(Newsfile Corp. - July 23, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc.("Eton" or the "Company") (NASDAQ: ETON). Such investors are advised to contact Robert S. Willoughby...(Newsfile)
July 21, 2023
3:30 pm ET	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON NEW YORK, NY / ACCESSWIRE / July 21, 2023 / Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc.("Eton" or the "Company") (NASDAQ:ETON). Such investors are advised to contact Robert S. Willoughby at...(Accesswire)
July 19, 2023
2:40 pm ET	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON(Globe Newswire)
July 17, 2023
5:46 pm ET	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON Pomerantz LLP is investigating claims on behalf of investors ofEton Pharmaceuticals, Inc.("Eton" or the "Company")(NASDAQ:ETON). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.comor 888-476-6529, ext. 7980. (PR Newswire)
4:05 pm ET	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the...(PR Newswire)
July 13, 2023
3:41 pm ET	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON NEW YORK, NY / ACCESSWIRE / July 13, 2023 / Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc.("Eton" or the "Company") (NASDAQ:ETON). Such investors are advised to contact Robert S. Willoughby at...(Accesswire)
July 12, 2023
1:14 pm ET	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON Pomerantz LLP is investigating claims on behalf of investors ofEton Pharmaceuticals, Inc.("Eton" or the "Company")(NASDAQ: ETON). Such investors are advised to contact Robert S.Willoughby at newaction@pomlaw.comor 888-476-6529, ext. 7980. (PR Newswire)
July 09, 2023
1:00 pm ET	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON(Globe Newswire)
Next >

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Postmarket

Change Since Close

Market Hours